122 related articles for article (PubMed ID: 29101032)
1. p.Q511L mutation of HNF1α in hepatocellular carcinoma suppresses the transcriptional activity and the anti-tumor effect of HNF1α.
Ding CH; Deng LF; Chen F; Ding K; Chen WS; Xie WF; Zhang X
Biochem Biophys Res Commun; 2018 Jan; 495(1):86-91. PubMed ID: 29101032
[TBL] [Abstract][Full Text] [Related]
2. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice.
Zeng X; Lin Y; Yin C; Zhang X; Ning BF; Zhang Q; Zhang JP; Qiu L; Qin XR; Chen YX; Xie WF
Hepatology; 2011 Dec; 54(6):2036-47. PubMed ID: 21898499
[TBL] [Abstract][Full Text] [Related]
4. [Hepatocellular carcinoma in an inflammatory adenoma with β-catenin mutation in a patient with hepatocellular adenomatosis due to germline mutation in HNF1α].
Ridder DA; Duret D; Wörns MA; Schotten S; Heinrich S; Kloth M; Springer E; Roth W; Straub BK
Z Gastroenterol; 2019 Jan; 57(1):46-51. PubMed ID: 30641602
[TBL] [Abstract][Full Text] [Related]
5. Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice.
Ni Q; Ding K; Wang KQ; He J; Yin C; Shi J; Zhang X; Xie WF; Shi YQ
FEBS Lett; 2017 Jul; 591(13):1947-1957. PubMed ID: 28547778
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
[TBL] [Abstract][Full Text] [Related]
7. Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma.
Yu HT; Yu M; Li CY; Zhan YQ; Xu WX; Li YH; Li W; Wang ZD; Ge CH; Yang XM
J Biol Chem; 2009 May; 284(20):13335-13347. PubMed ID: 19304666
[TBL] [Abstract][Full Text] [Related]
8. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
[TBL] [Abstract][Full Text] [Related]
9. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dynamics Simulations Predict That rSNP Located in the
Španinger E; Potočnik U; Bren U
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33371430
[TBL] [Abstract][Full Text] [Related]
11. Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.
Willson JS; Godwin TD; Wiggins GA; Guilford PJ; McCall JL
J Hepatol; 2013 Oct; 59(4):904-7. PubMed ID: 23707370
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of hepatocyte nuclear factors 4α and 1α identified by tissue microarray in resectable hepatocellular carcinoma.
Shim JH; Kang HJ; Han S; Lee YJ; Lee SG; Yu E; Lee HC
J Gastroenterol Hepatol; 2014 Mar; 29(3):524-32. PubMed ID: 23981200
[TBL] [Abstract][Full Text] [Related]
13. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
[TBL] [Abstract][Full Text] [Related]
15. The G115S mutation associated with maturity-onset diabetes of the young impairs hepatocyte nuclear factor 4alpha activities and introduces a PKA phosphorylation site in its DNA-binding domain.
Oxombre B; Kouach M; Moerman E; Formstecher P; Laine B
Biochem J; 2004 Nov; 383(Pt. 3):573-80. PubMed ID: 15233628
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
[TBL] [Abstract][Full Text] [Related]
17. [Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomatosis in a patient with maturity-onset diabetes of the young type 3: case report and literature review].
Hirata E; Shimizu S; Umeda S; Kobayashi T; Nakano M; Higuchi H; Serizawa H; Iwasaki N; Morinaga S; Tsunematsu S
Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1696-704. PubMed ID: 26346360
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma.
Jeannot E; Poussin K; Chiche L; Bacq Y; Sturm N; Scoazec JY; Buffet C; Van Nhieu JT; Bellanné-Chantelot C; de Toma C; Laurent-Puig P; Bioulac-Sage P; Zucman-Rossi J
Cancer Res; 2007 Mar; 67(6):2611-6. PubMed ID: 17363580
[TBL] [Abstract][Full Text] [Related]
19. [Mutations of the tumor suppressor Kruppel-like factor 6 (KLF6) gene in hepatocellular carcinoma and its effect of growth suppression on human hepatocellular carcinoma cell line HepG2].
Pan XC; Chen Z; Chen F; Chen XH; Zhou C; Yang ZG
Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):109-13. PubMed ID: 16494780
[TBL] [Abstract][Full Text] [Related]
20. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
